Trials / Completed
CompletedNCT02132533
Nifedipine for Acute Tocolysis of Preterm Labor
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 88 (actual)
- Sponsor
- University of Texas Southwestern Medical Center · Academic / Other
- Sex
- Female
- Age
- 16 Years – 44 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if nifedipine treatment of women in preterm labor receiving corticosteroids results in postponement of delivery when compared to placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nifedipine | Nifedipine 20 mg orally, then nifedipine 20 mg orally after 90 minutes if still contracting. Continue nifedipine 20 mg orally every 4 hours after the first dose for 48 hours. |
| DRUG | Placebo | Placebo orally, then placebo orally after 90 minutes if still contracting. Continue placebo orally every 4 hours after the first dose for 48 hours. |
| OTHER | Usual care | Usual evaluation, monitoring and care for women with preterm labor. |
Timeline
- Start date
- 2014-05-05
- Primary completion
- 2018-10-29
- Completion
- 2018-10-29
- First posted
- 2014-05-07
- Last updated
- 2020-12-21
- Results posted
- 2020-02-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02132533. Inclusion in this directory is not an endorsement.